GuoBang Pharmaceuticals: Cumulative repurchase of approximately 7.77 million shares

robot
Abstract generation in progress

Meiri AI Express: Guobang Pharmaceutical announced on the evening of March 2nd that as of the disclosure date of this announcement, the company’s share repurchase plan has reached the minimum repurchase amount. The plan has been completed, and the company has actually repurchased approximately 7.77 million shares, accounting for 1.39% of the total share capital. The highest purchase price was 24.59 yuan per share, the lowest was 18.61 yuan per share, and the total funds paid were about 159 million RMB.

Meiri Headlines (nbdtoutiao)—Exclusive interview with Zhu Guangyao, former Vice Minister of Finance: During the 14th Five-Year Plan period, China’s nominal GDP growth rate is expected to reach about 7%, with the new economic total expected to exceed 36 trillion yuan.

(Reporter Zeng Jianhui)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Operate at your own risk.

Daily Economic News

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)